Key facts
- Pixelgen Technologies’s last known valuation is $26.8M (Oct 2023).
- It has raised $28.8M; the latest was Later Stage VC ($14.4M) in Jun 2025.
- Notable investors include European Innovation Council, Industrifonden, Colibri Ventures, European Innovation Council (Belgium), Fibonacci Growth Capital — 6 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 6 names
- ·Watchlist + deal alerts for Pixelgen Technologies
- ·The full record, as it builds
Funding rounds
No funding rounds for Pixelgen Technologies are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Pixelgen Technologies
Developer of bio-analytical tools designed for biomedical research and diagnostics. The company develops novel analytical methods and products capable of seeing the inner workings of life and delivering these to researchers and drug developers, enabling clients to gain new insights into biomedicine and ultimately improve health.
- Sector
- Healthcare
- HQ
- Stockholm, Sweden
- Founded
- 2020
- Employees
- 31
- Website
- pixelgen.com/
- Ownership
- Privately Held (backing)
Pixelgen Technologies doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Pixelgen Technologies shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Pixelgen Technologies in its N-PORT filings yet. We sweep new filings monthly.